RFK Jr. has proposed a permissive FDA approach to unproven peptides, Ars Technica reports.

FDA scientists said none of the popular peptides discussed had been shown to be safe or effective.

Details of the proposal, and whether it is formal policy, are not established in the reporting.

Kennedy calls himself a “big fan” of peptides and says he has used them himself.

The FDA had listed BPC-157 and other injectable peptides as too risky for pharmacies to compound.

On July 23, an FDA advisory panel narrowly backed adding six of seven peptides to a compounding list.

That vote does not make the peptides FDA-approved, and the FDA must still act through rulemaking.

Read the full article for more details on the unproven peptides debate.